Rigetti Computing Stock Earnings Reports

Key points for investors:

- Product/technology: Rigetti launched general availability of its 108‑qubit Cepheus-1-108Q (12 × 9‑qubit chiplets), claiming it is the largest modular, generally available gate-based system on the market. Reported median 2‑qubit gate fidelity ~99.1% and single‑qubit fidelity ~99.9%; prototype adiabatic CZ gates have achieved up to 99.9% fidelity at 28 ns.

- Market traction: Cepheus-1-108Q is available via Rigetti QCS, AWS Braket, Microsoft Azure Quantum and qBraid. Growing on‑premises demand driven by Novera QPU sales to universities, national labs and government programs (including an $8.4M C‑DAC order in India). Q1 revenue was $4.4M (vs. $1.5M a year ago) driven largely by system deliveries.

- Financials & balance sheet: Q1 revenue $4.4M; gross margin 31%; operating expenses $27.3M; non‑GAAP net loss $14.7M (‑$0.04 per share). GAAP net income included large noncash fair‑value gains. Cash, cash equivalents and AFS investments ≈ $569M at quarter end; no debt. CapEx elevated in 2026 for Fab‑1 and dilution refrigeration / infrastructure.

- Strategy & roadmap: Management reiterates disciplined capital allocation focused on R&D and organic execution, a planned up‑to‑$100M multi‑year investment in the U.K., and a stated objective to reach “quantum advantage” in ~3 years by scaling chiplet architecture toward ~1,000 qubits while improving fidelity and maintaining superconducting speed advantages (~50–70 ns gate speeds).

- Near‑term expectations & risks: Management expects remainder of previously announced Novera revenue to be recognized in Q2 and the C‑DAC system to be recognized in Q4 after installation/acceptance. Key execution risks remain: scaling fidelities/coherence as qubit count increases, timing variability of system deliveries, and continued R&D/capex requirements.

Bottom line: Rigetti demonstrated a meaningful technical milestone with a generally available 108‑qubit modular system and is showing early commercial traction; the company has a strong cash position to fund its multi‑year roadmap but remains in an R&D and scaleup phase with quarterly revenue variability and elevated investment needs.